Cancers 2012, 4(2), 504-522; doi:10.3390/cancers4020504
Review

Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1

1 Department of Clinical Physiopathology, Surgical Unit, Medical School, University of Florence, Largo Brambilla n° 3, Florence 50134, Italy 2 Department of Internal Medicine, Medical School and Regional Centre for Hereditary Endocrine Tumors, University of Florence, Largo Brambilla n° 3, Florence 50134, Italy
* Author to whom correspondence should be addressed.
Received: 17 February 2012; in revised form: 10 April 2012 / Accepted: 18 April 2012 / Published: 7 May 2012
(This article belongs to the Special Issue Neuroendocrine Tumors)
PDF Full-text Download PDF Full-Text [153 KB, uploaded 7 May 2012 11:19 CEST]
Abstract: We reviewed the literature about entero-pancreatic neuroendocrine tumors in Multiple Endocrine Neoplasia type 1 syndrome (MEN1) to clarify their demographic features, localization imaging, practice, and appropriate therapeutical strategies, analyzing the current approach to entero-pancreatic neuroendocrine tumors in MEN1. Despite the fact that hyperparathyroidism is usually the first manifestation of MEN1, the penetrance of these tumors is similar. They are characterized by multiplicity of lesions, variable expression of the tumors, and propensity for malignant degeneration. Both the histological type and the size of MEN1 neuroendocrine tumors correlate with malignancy. Monitoring of pancreatic peptides and use of imaging exams allow early diagnosis and prompt surgical treatment, resulting in prevention of metastatic disease and improvement of long-term survival. Surgery is often the treatment of choice for MEN1-neuroendocrine tumors. The rationale for surgical approach is to curtail malignant progression of the disease, and to cure the associated biochemical syndrome, should it be present.
Keywords: gastro-entero-pancreatic neuroendocrine tumors; MEN1; surgery; insulinoma; gastrinoma

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Tonelli, F.; Giudici, F.; Giusti, F.; Brandi, M.L. Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1. Cancers 2012, 4, 504-522.

AMA Style

Tonelli F, Giudici F, Giusti F, Brandi ML. Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1. Cancers. 2012; 4(2):504-522.

Chicago/Turabian Style

Tonelli, Francesco; Giudici, Francesco; Giusti, Francesca; Brandi, Maria Luisa. 2012. "Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1." Cancers 4, no. 2: 504-522.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert